Georgakopoulos, Nikolaos D
Wells, Geoff
Campanella, Michelangelo
Article History
Received: 30 June 2016
Accepted: 6 December 2016
First Online: 19 January 2017
Competing interests
: N.D.G. and G.W. are shareholders in Keregen Therapeutics Ltd, a small and medium-sized enterprise (SME) with a research interest in Nrf2 inducing compounds.